生物标志物 生物标志物
Simone P Zehntner1, Jean-Philippe Coutu1, Felix Carbonell1
1Biospective Inc., Montreal, QC, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
先进的MRI技术精确地追踪皮层基底退化 (CBD) 的进展,并有助于将其与其他疾病区分开来. 这种成像方法可以加速罕见神经退行性疾病的临床试验.
科学领域:
- 神经成像是一种神经成像.
- 神经退行性疾病 神经退行性疾病
- 生物标志物发现发现
背景情况:
- 皮层骨干退化 (CBD) 是一种罕见的神经退行性疾病,其特征是蛋白积累和神经元损失.
- CBD与其他帕金森综合征具有临床相似之处,这给诊断带来了挑战.
- 包括体积和扩散MRI (dMRI) 在内的MRI生物标志物对于监测疾病进展和优化临床试验至关重要.
研究的目的:
- 使用先进的成像技术探索皮层骨干退化 (CBD) 的进展.
- 为了区分CBD与类似的神经退行性疾病,如渐进性超核麻 (PSP).
- 评估高级MRI在减少临床试验样本大小要求方面的实用性.
主要方法:
- 利用了CBD,PSP和健康对照队伍的MRI数据,这些人来自4重复陶病神经成像计划 (4RTNI) 和前叶退化神经成像计划 (FTLDNI).
- 使用PIANOTM软件平台进行全自动体积和灰色物质密度评估.
- 分析的扩散MRI (dMRI) 度量,包括辐射扩散率 (RD) 和自由水 (FW),以评估微观结构变化和计算样本大小,用于临床试验的疗效.
主要成果:
- 在12个月的时间里,CBD受试者表现出加速的大脑缩,感觉运动皮层,皮层和皮层的灰质密度显著下降.
- 体积测量分析显示2.5%-5%的区域缩小和和海马体的皮下缩.
- 扩散MRI显示白质和皮质扩散率的变化高达5%,PIANOTM软件与FreeSurfer相比显著减少了所需的样本大小.
结论:
- 综合体积和扩散分析的高级MRI准确地追踪了CBD的进展,并有助于将其与PSP区分开来.
- 这种方法可以通过尽量减少样本大小要求和促进疾病修饰疗法的早期评估来加速临床试验.
- 整合强大的成像生物标志物对于提高CBD等罕见神经退行性疾病的诊断准确性和治疗干预措施至关重要.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516